Cargando…

Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children

BACKGROUND: Juvenile dermatomyositis (JDM) is a rare and sometimes fatal disease in children. The anti-NXP2 antibody is one of the most common antibodies and muscle ischaemia associated with NXP2 autoantibodies was a severe subtype of JDM. Further information is needed regarding clinical characteris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xinning, Ding, Yuchuan, Zhou, Zhixuan, Hou, Jun, Xu, Yingjie, Li, Jianguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788734/ https://www.ncbi.nlm.nih.gov/pubmed/33407621 http://dx.doi.org/10.1186/s12969-020-00492-z

Ejemplares similares

Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature
por: Xu, Yingjie, et al.
Publicado: (2021)

An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations
por: Fredi, Micaela, et al.
Publicado: (2022)

JDM update September 2014
por: Pilkington, Clarissa
Publicado: (2014)

A Case of Dermatomyositis Coexisting with Both Anti-Mi-2 and Anti-NXP-2 Antibodies
por: Ito, Mitsuru, et al.
Publicado: (2020)

Rapidly progressive interstitial pneumonia associated with anti-NXP2 antibody secondary to malignancy
por: Wuthithepbuncha, Nataphon, et al.
Publicado: (2022)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series
por: Toplak, Natasa, et al.
Publicado: (2022)

Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody
por: Gossez, Morgane, et al.
Publicado: (2015)

A rare case of NXP-2 positive dermatomyositis
por: Khan, Nariman, et al.
Publicado: (2021)

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era
por: Smith, S, et al.
Publicado: (2008)

Anti-NXP2-antibody-positive immune-mediated necrotizing myopathy associated with acute myeloid leukemia: A case report
por: Su, Lina, et al.
Publicado: (2018)

Dermatomyosite à anticorps anti-NXP2 et COVID-19 : comorbidité ou complication ?
por: Hecham, Nassima, et al.
Publicado: (2023)

NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation
por: Butt, Zeeshan, et al.
Publicado: (2017)

A case of anti-NXP2 antibody-positive dermatomyositis with improvement of clinical symptoms and disappearance of autoantibody after resection of uterine cancer
por: Fushida, Natsumi, et al.
Publicado: (2021)

Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)
por: McCann, Liza J, et al.
Publicado: (2011)

Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM)
por: Abdul-Aziz, Rabheh, et al.
Publicado: (2017)

8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
por: Ferrari, C, et al.
Publicado: (2008)

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis
por: Ceribelli, Angela, et al.
Publicado: (2012)

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
por: Tansley, Sarah L., et al.
Publicado: (2014)

Corrigendum to “NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation”
por: Butt, Zeeshan, et al.
Publicado: (2018)

Clinical Images: Degos‐like lesions in association with NXP‐2 dermatomyositis
por: Alhassan, Eaman, et al.
Publicado: (2023)

Case of juvenile dermatomyositis (JDM), thrombotic thrombocytopenic purpura (TTP), and Purtscher retinopathy
por: Goldzweig, Ofra, et al.
Publicado: (2012)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use
por: McCann, Liza J., et al.
Publicado: (2015)

JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology
por: Ll Wilkinson, Meredyth G., et al.
Publicado: (2021)

Currently recommended skin scores correlate highly in the assessment of patients with Juvenile Dermatomyositis (JDM)
por: Gebreamlak, Alexander, et al.
Publicado: (2023)

Characterising inflammatory markers in two childhood autoimmune diseases (JIA and JDM) pre and post methotrexate
por: Ursu, S, et al.
Publicado: (2011)

Multiple neurological manifestations in a patient with systemic lupus erythematosus and anti-NXP2-positive myositis: A case report
por: Cao, Xiaojie, et al.
Publicado: (2021)

NXP032 ameliorates cognitive impairment by alleviating the neurovascular aging process in aged mouse brain
por: Lee, Jae-Min, et al.
Publicado: (2023)

Race is a risk factor for calcinosis in patients with JDM – early results from the CARRAnet registry study
por: Hoeltzel, Mark F, et al.
Publicado: (2012)

Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis
por: Ding, Yuchuan, et al.
Publicado: (2021)

OA05 Clinical presentation, risk factors and prognosis of MDA5-positive JDM; clinical diversity and red flags
por: McLellan, Kirsty, et al.
Publicado: (2022)

P11 An unusual case of Systemic Sclerosis/JDM overlap in a child with PAX8-related congenital hypothyroidism
por: Smith, Rachel, et al.
Publicado: (2022)

NXP032 Ameliorates Aging-Induced Oxidative Stress and Cognitive Impairment in Mice through Activation of Nrf2 Signaling
por: Lee, Jae-Min, et al.
Publicado: (2022)

NXP081, DNA Aptamer–Vitamin C Complex Ameliorates DNFB-Induced Atopic Dermatitis in Balb/c Mice
por: Lee, Sanggon, et al.
Publicado: (2023)

Juvenile Dermatomyositis (JDM) Complicated by Thrombotic Thrombocytopenic Purpura (TTP) and Purtscher's Retinopathy Responsive to Rituximab: Case Report and Literature Review
por: Gullapalli, Keerthi, et al.
Publicado: (2020)

NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-α-synuclein mouse model of Parkinson’s disease
por: Song, Min Kyung, et al.
Publicado: (2022)

How do tissue infiltrating B cells and plasma cells correlate with other inflammatory features in muscle tissue from patients with JDM?
por: Sag, Erdal, et al.
Publicado: (2014)

P14 Challenges in treating anti-melanoma differentiation associated gene 5 (MDA5) antibody positive juvenile dermatomyositis (JDM) with interstitial lung disease (ILD) complicated by pneumocytis jirovecii pneumonia (PCP): a case report
por: Affendi, Sharifah Adrianna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gmt36le7b2qfrsshp1nrd2us72